Papers by Adrian L. Harris
Page 10 · newest first
- Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesisBritish Journal of Cancer · 2002
- The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancerBritish Journal of Cancer · 2002
- Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non‐Hodgkin's lymphomaHistopathology · 2002
- Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survivalBritish Journal of Cancer · 2001
- Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast CarcinomaJournal of Clinical Oncology · 2001
- Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancerThe Journal of Pathology · 2001
- Hypoxia and oxidative stress in breast cancer Hypoxia and tumourigenesisBreast Cancer Research · 2001
- Cellular mechanisms of bone resorption in breast carcinomaBritish Journal of Cancer · 2001
- In vivo glycosylation of mucin tandem repeatsGlycobiology · 2001
- Modelling Macrophage Infiltration into Avascular TumoursComputational and Mathematical Methods in Medicine · 2001
- Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase CJournal of Clinical Oncology · 2001
- Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathwayBritish Journal of Cancer · 2001
- The angiogenic pathway ?vascular endothelial growth factor/flk-1(KDR)-receptor? in rheumatoid arthritis and osteoarthritisThe Journal of Pathology · 2001
- Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasionBritish Journal of Cancer · 2001
- The angiogenic ?vascular endothelial growth factor/flk-1(KDR) receptor? pathway in patients with endometrial carcinomaCancer · 2001
- A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune ResponseThe Journal of Immunology · 2000
- Role of Matrix Metalloproteinase 9 in Pituitary Tumor BehaviorThe Journal of Clinical Endocrinology & Metabolism · 2000
- Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alphaBritish Journal of Cancer · 2000
- The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivoBritish Journal of Cancer · 2000
- Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testisBJU International · 2000
- Current Status Of Antiangiogenic FactorsBritish Journal of Haematology · 2000
- Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcomeJournal of Endocrinology · 2000
- Cid1, a Fission Yeast Protein Required for S-M Checkpoint Control when DNA Polymerase δ or ɛ Is InactivatedMolecular and Cellular Biology · 2000
- von Hippel-Lindau Syndrome: Target for Anti-Vascular Endothelial Growth Factor (VEGF) Receptor TherapyThe Oncologist · 2000
- Macrophage infiltration is associated with VEGF and EGFR expression in breast cancerThe Journal of Pathology · 2000
- Angiogenesis in Pituitary Adenomas and the Normal Pituitary GlandThe Journal of Clinical Endocrinology & Metabolism · 2000
- Macrophage infiltration is associated with VEGF and EGFR expression in breast cancerThe Journal of Pathology · 2000
- Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomyBritish journal of surgery · 2000
- NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell lineBritish Journal of Cancer · 2000
- Elevated serum vascular endothelial growth factor in patients with hormone‐escaped prostate cancerBJU International · 2000
- Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomasThe Journal of Pathology · 2000
- Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazineBritish Journal of Cancer · 2000
- Serum vascular endothelial growth factor load and interleukin-6 in cancer patientsBritish Journal of Cancer · 2000
- Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progressionBritish Journal of Cancer · 2000
- Macrophage responses to hypoxia: relevance to disease mechanismsJournal of Leukocyte Biology · 1999
- Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assayBritish Journal of Cancer · 1999
- Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC)The Journal of Pathology · 1999
- Combined role of tumor angiogenesis,bcl-2, and p53 expression in the prognosis of patients with colorectal carcinomaCancer · 1999
- Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancerBritish Journal of Cancer · 1999
- Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment: Challenges for Drug Development?JNCI Journal of the National Cancer Institute · 1999
- Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinomaCancer · 1999
- Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinomaCancer · 1999
- Angiogenesisvs. response after combined chemoradiotherapy of squamous cell head and neck cancerInternational Journal of Cancer · 1999
- Caffeine can override the S-M checkpoint in fission yeastJournal of Cell Science · 1999
- Urinary Vascular Endothelial Growth Factor and Its Correlation With Bladder Cancer Recurrence RatesThe Journal of Urology · 1999
- Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancerBritish Journal of Cancer · 1999
- Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breastBritish Journal of Cancer · 1999
- Vascular Endothelial Growth Factor is a Predictor of Relapse and Stage Progression in Superficial Bladder CancerThe Journal of Urology · 1998
- Vascular Endothelial Growth Factor is a Predictor of Relapse and Stage Progression in Superficial Bladder CancerThe Journal of Urology · 1998
- Expression of VEGF in routinely fixed material using a new monoclonalThe Journal of Pathology · 1998